NEW YORK, June 1, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at
Monteverde & Associates PC, a boutique securities firm
headquartered at the Empire State Building in New York City announces that a class action
lawsuit has been filed in the U.S. District Court for the
Southern District of New York
against Akari Therapeutics, Plc. (NasdaqCM: AKTX)("Akari
Therapeutics" or the "Company") on behalf of purchasers of the
Company's securities between March
30, 2017 and May 11, 2017,
inclusive (the "Class Period").
The lawsuit is based on whether Akari Therapeutics and its
executives violated federal securities law by misleading investors
by making false and/or misleading statements regarding the
Company's business, operational and compliance policies.
Specifically, Chief Executive Officer Dr. Gur Roshwalb and possibly
other executives, were involved in publishing false information
about the Company, including false information regarding the Phase
2 PNH trial of Coversin.
On May 11, 2017, Akari
Therapeutics announced that Dr. Roshwalb has been placed on
administrative leave while the Board of Directors reviews whether
Dr. Roshwalb and other executives were involved in a materially
inaccurate research report that was released and then withdrawn on
April 26, 2017 by Edison Investment
Research Ltd. When the information was revealed to the public, the
value of Akari Therapeutics stock dropped, causing losses to its
shareholders.
Mr. Monteverde would like to personally discuss with you how
to potentially recover your monetary losses, if incurred during the
Class Period.
If you wish to serve as lead plaintiff, you must move the Court
no later than July 11,
2017. Any member of the putative class may move
the Court to serve as lead plaintiff through counsel of their
choice, or may choose to do nothing and remain an absent class
member.
Click here for more information:
http://monteverdelaw.com/securities/. It is free
and there is no cost or obligation to you.
Monteverde & Associates PC is a boutique class action
securities and consumer litigation law firm committed that has
recovered millions of dollars and is committed to protecting
shareholders and consumers from corporate wrongdoing.
Monteverde & Associates PC lawyers have significant experience
litigating Mergers & Acquisitions and Securities Class Actions,
whereby they protect investors by recovering money and remedying
corporate misconduct.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates
PC. Prior results do not guarantee a similar outcome with
respect to any future matter.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/urgent-monteverde--associates-pc-invites-akari-therapeutics-plc-shareholders-with-significant-losses-to-contact-the-firm-immediately--aktx-300467466.html
SOURCE Monteverde & Associates PC